Keyphrases
Sub-volume
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Metabolically Active
100%
Dose Escalation
100%
PET-based
100%
Dose Painting
100%
Tumor
42%
Cm(III)
42%
Treatment Plan
28%
Metabolic
28%
At-risk
28%
Hypoxic Volume
28%
High Dose
14%
Radiotherapy
14%
Hypoxia
14%
Primary Tumor
14%
Non-small Cell Lung Cancer Patients
14%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
14%
PET Scan
14%
SUVmax
14%
Imaging Biomarkers
14%
Prescribed Dose
14%
Boost Volume
14%
Increased Dose
14%
INIS
doses
100%
cancer
100%
volume
100%
positron computed tomography
100%
paintings
100%
lung cells
100%
patients
40%
tumors
40%
comparative evaluations
30%
risks
20%
organs
20%
increasing
10%
hypoxia
10%
biological markers
10%
radiotherapy
10%
cat scanning
10%
Medicine and Dentistry
Neoplasm
100%
Positron Emission Tomography
100%
Non Small Cell Lung Cancer
100%
Positron Emission Tomography-Computed Tomography
33%
Biological Marker
33%
Drug Megadose
33%
Hypoxia
33%
Radiation Therapy
33%
Low Drug Dose
33%
Primary Tumor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Non Small Cell Lung Cancer
100%
Biological Marker
33%
Primary Tumor
33%
Hypoxia
33%
Neuroscience
Positron Emission Tomography
100%
Positron Emission Tomography-Computed Tomography
33%
Radiation Therapy
33%